EUVIMEDEUVIMED entdecken
Crossref

Astragalus Polysaccharide Alleviates Hyperlipidemia via the miR‐128‐3p/NRF2/Antioxidant Pathway

Qianfa Yuan iD, Chunlei Zhang, Zemin Yang

Journal of Food Science · 2026-04 · 91 (4)

DOI: 10.1111/1750-3841.71035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Food Science, online erschienen am 10.04.2026. Verfasst von Qianfa Yuan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Psychiatric Center, Fujian Clinical Research Center for Mental Disorders, Xiamen Xian Yue Hospital, Xian Yue Hospital Affiliated with Xiamen M…. Hauptthemen laut MEDLINE: Hyperlipidemias, Polysaccharides, NF-E2-Related Factor 2, MicroRNAs. Die Arbeit nennt 76 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Science and Technology Planning Project of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperlipidemia, a common metabolic disorder marked by elevated serum lipids like total cholesterol (TC), triglycerides (TG), and low‐density lipoprotein cholesterol (LDL‐C), raises risks for cardiovascular diseases, atherosclerosis, nonalcoholic fatty liver disease, and diabetes. Conventional treatments like statins have limitations, including liver damage and resistance, driving interest in natural compounds with multi‐target, low‐toxicity effects. This study assessed Astragalus polysaccharide (APS), a traditional Chinese medicine component with antioxidant and metabolic‐regulatory properties, for its therapeutic effects on hyperlipidemic rats and its mechanism via the miR‐128‐3p/NRF2/antioxidant pathway. SD rats were grouped into normal, model, simvastatin, and APS. Except normal, all received high‐fat diet for 8 weeks to induce hyperlipidemia. Then, APS (700 mg/kg) or simvastatin (6.7 mg/kg) was administered via gavage for 8 weeks; controls received saline. Serum indices were monitored periodically; pancreatic and hepatic tissues were analyzed histologically and molecularly. In vitro, lipid accumulation was induced in BRL and HepG2 cells with oleic/palmitic acids (2:1). Optimal APS dose/time was determined by CCK‐8; lipid and oxidative markers were measured. A high‐fat diet caused hyperlipidemia, elevating lipids, body weight, and energy intake. APS reduced glucose/lipid levels, and transaminase activity and improved pancreatic/hepatic pathology, including β‐cell function. APS lowered MDA and miR‐128‐3p while boosting T‐SOD and hepatic NRF2. In cells, APS reversed lipid buildup and oxidative stress. APS mitigates hyperlipidemia via the miR‐128‐3p/NRF2/antioxidant pathway, providing a multi‐target strategy for lipid metabolism, oxidative stress, and organ protection. This supports natural interventions for hyperlipidemia, especially with glucose/organ issues, meriting clinical exploration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperlipidemiasPolysaccharidesNF-E2-Related Factor 2MicroRNAsAntioxidantsAstragalus PlantAnimalsRats, Sprague-DawleyRatsMaleHumansDiet, High-FatOxidative StressLiverHep G2 CellsTriglyceridesSignal Transduction

Stichwörter der Autor:innen

AntioxidantAstragalus polysaccharideNRF2hyperlipidemiamiR‐128‐3p

Substanzen

PolysaccharidesNF-E2-Related Factor 2MicroRNAsAntioxidantsTriglycerides

Autor:innen und Institutionen

  • Fujian Psychiatric Center, Fujian Clinical Research Center for Mental Disorders, Xiamen Xian Yue Hospital, Xian Yue Hospital Affiliated with Xiamen Medical College, Xiamen, Fujian, China.
  • Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
  • Department of Stomatology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.

ORCID-Profile: Qianfa Yuan

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • Science and Technology Planning Project of Guangdong Province
  • Xiamen Medical and Health Guidance Project
  • Fujian Provincial Joint Project on Scientific and Technological Innovation

Zitieren

APA

Yuan, Q., Zhang, C., & Yang, Z. (2026). Astragalus Polysaccharide Alleviates Hyperlipidemia via the miR‐128‐3p/NRF2/Antioxidant Pathway. Journal of Food Science, 91(4). https://doi.org/10.1111/1750-3841.71035

Vancouver

Yuan Q, Zhang C, Yang Z. Astragalus Polysaccharide Alleviates Hyperlipidemia via the miR‐128‐3p/NRF2/Antioxidant Pathway. Journal of Food Science. 2026;91(4). doi:10.1111/1750-3841.71035

BibTeX
@article{Yuan2026,
  author = {Yuan, Qianfa and Zhang, Chunlei and Yang, Zemin},
  title = {Astragalus Polysaccharide Alleviates Hyperlipidemia via the miR‐128‐3p/NRF2/Antioxidant Pathway},
  journal = {Journal of Food Science},
  year = {2026},
  volume = {91},
  number = {4},
  doi = {10.1111/1750-3841.71035}
}
Kostenlos starten →